Camelot Portfolios, LLC Eli Lilly & CO Transaction History

Camelot Portfolios, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $1.29 Million - $1.61 Million	1,775 New	1,775 $1.61 Million
Q4 2023 Jan 23, 2024	BUY	$525.19 - $619.13 $783,583 - $923,741	1,492 New	1,492 $869,000
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $516,318 - $641,652	-2,200 Closed	0 $0
Q4 2021 Jan 04, 2022	BUY	$224.85 - $279.04 $494,670 - $613,888	2,200 New	2,200 $608,000
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $487,520 - $599,962	-2,200 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$180.55 - $233.54 $6,319 - $8,173	-35 Reduced 1.57%	2,200 $505,000
Q1 2021 Apr 21, 2021	BUY	$164.32 - $212.72 $367,255 - $475,429	2,235 New	2,235 $418,000
Q3 2020 Oct 19, 2020	SELL	$146.22 - $169.13 $394,940 - $456,820	-2,701 Closed	0 $0
Q2 2020 Jul 30, 2020	SELL	$136.42 - $164.18 $27,420 - $33,000	-201 Reduced 6.93%	2,701 $444,000
Q1 2020 Apr 28, 2020	BUY	$119.05 - $147.35 $238 - $294	2 Added 0.07%	2,902 $403,000
Q4 2019 Jan 16, 2020	BUY	$106.92 - $132.43 $106 - $132	1 Added 0.03%	2,900 $381,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $223,425 - $247,980	2,899	2,899 $248,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

Stay updated on Camelot Portfolios, LLC with notifications on news.